BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21930380)

  • 1. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
    Qiao Z; Wang W; Wang L; Wen D; Zhao Y; Wang Q; Meng Q; Chen G; Wu Y; Zhou H
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6389-92. PubMed ID: 21930380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SENP1 inhibitors through in silico screening and rational drug design.
    Zhao Y; Wang Z; Zhang J; Zhou H
    Eur J Med Chem; 2016 Oct; 122():178-184. PubMed ID: 27344494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRET-based in vitro assays for the analysis of SUMO protease activities.
    Tatham MH; Hay RT
    Methods Mol Biol; 2009; 497():253-68. PubMed ID: 19107423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
    Su L; Fang H; Yang K; Xu Y; Xu W
    Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family.
    Drag M; Mikolajczyk J; Krishnakumar IM; Huang Z; Salvesen GS
    Biochem J; 2008 Jan; 409(2):461-9. PubMed ID: 17916063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of Arabidopsis thaliana SUMO pathways in E. coli: functional evaluation of SUMO machinery proteins and mapping of SUMOylation sites by mass spectrometry.
    Okada S; Nagabuchi M; Takamura Y; Nakagawa T; Shinmyozu K; Nakayama J; Tanaka K
    Plant Cell Physiol; 2009 Jun; 50(6):1049-61. PubMed ID: 19376783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO proteases as potential targets for cancer therapy.
    Bialik P; Woźniak K
    Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO proteases: redox regulation and biological consequences.
    Xu Z; Chan HY; Lam WL; Lam KH; Lam LS; Ng TB; Au SW
    Antioxid Redox Signal; 2009 Jun; 11(6):1453-84. PubMed ID: 19186998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
    Chen Y; Wen D; Huang Z; Huang M; Luo Y; Liu B; Lu H; Wu Y; Peng Y; Zhang J
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6867-70. PubMed ID: 23044371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Tools and Biochemical Assays for SUMO Specific Proteases (SENPs).
    Jia Y; Claessens LA; Vertegaal ACO; Ovaa H
    ACS Chem Biol; 2019 Nov; 14(11):2389-2395. PubMed ID: 31361113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance.
    Vigodner M; Weisburg JH; Shrivastava V; Marmor RA; Fathy J; Skop N
    Cell Tissue Res; 2009 May; 336(2):277-86. PubMed ID: 19326147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties.
    Zhang M; Nguyen JT; Kumada HO; Kimura T; Cheng M; Hayashi Y; Kiso Y
    Bioorg Med Chem; 2008 May; 16(10):5795-802. PubMed ID: 18400502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
    Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W
    Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
    Yang W; Wang L; Paschen W
    J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO-specific proteases: a twist in the tail.
    Hay RT
    Trends Cell Biol; 2007 Aug; 17(8):370-6. PubMed ID: 17768054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SUMO-specific protease 1 and cancer].
    Cheng JK
    Ai Zheng; 2008 Jul; 27(7):771-4. PubMed ID: 18606075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of sumoylated proteins.
    Park-Sarge OK; Sarge KD
    Methods Mol Biol; 2009; 464():255-65. PubMed ID: 18951189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.